Junctional adhesion molecules 2 and 3 may potentially be involved in progression of gastric adenocarcinoma tumors

Medical Oncology

Volumn 30, Issue 1, 2013, Pages

  Hajjari, Mohammadreza ^a   Behmanesh, Mehrdad ^a   Sadeghizadeh, Majid ^a   Zeinoddini, Mehdi ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b Mallek Ashtar University of Technology   (Iran)

Author keywords

Adenocarcinoma; Gastric cancer; qRT PCR; Tight junction

Indexed keywords

COMPLEMENTARY DNA; JUNCTIONAL ADHESION MOLECULE B; JUNCTIONAL ADHESION MOLECULE C; CELL ADHESION MOLECULE; JAM2 PROTEIN, HUMAN; JAM3 PROTEIN, HUMAN; TRANSCRIPTOME; TUMOR MARKER;

ACTIN FILAMENT; ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; STOMACH ADENOCARCINOMA; TIGHT JUNCTION; TUMOR DIFFERENTIATION; ADENOCARCINOMA; BIOSYNTHESIS; METABOLISM; MIDDLE AGED; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH TUMOR; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CELL ADHESION MOLECULES; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL;

MLCS; MLOWN;

EID: 84880646270     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-012-0380-z     Document Type: Article

References (32)

1. Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol. 2001;2:285-93.
2. Bazzoni G, The JAM family of junctional adhesion molecules. Curr Opin Cell Biol. 2003;15:525-30.
3. Turksen K, Troy TC. Junctions gone bad: claudins and loss of the barrier in cancer. Biochim Biophys Acta. 2011;1816:73-9.
4. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110:673-87.
5. Palmeri D, van Zante A, Huang CC, Hemmerich S, Rosen SD. Vascular endothelial junction-associated molecule, a novel member of the immunoglobulin superfamily, is localized to intercellular boundaries of endothelial cells. J Biol Chem. 2000;275:19139-45.
6. Tenan M, Aurrand-Lions M, Widmer V, Alimenti A, Burkhardt K, Lazeyras F, et al. Cooperative expression of junctional adhesion molecule-C and -B supports growth and invasion of Glioma. Glia. 2010;58:524-37.
7. Mandicourt G, Iden S, Ebnet K, Aurrand-Lions M, Imhof BA. JAM-C regulates tight junctions and integrin-mediated cell adhesion and migration. J Biol Chem. 2007;282:1830-7.
8. Oster B, Thorsen K, Lamy P, Wojdacz TK, Hansen LL, Birkenkamp- Demtröder K, et al. Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas. Int J Cancer. 2011;129:2855-66.
9. Resende C, Thiel A, Machado JC, RistimaÂ̈ki A. Gastric cancer: basic aspects. Helicobacter. 2011;16:38-44.
10. Vogiatzi P, Vindigni C, Roviello F, Renieri A, Giordano A. Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis. J Cell Physiol. 2007;211:287-95.
11. Johnson AH, Frierson HF, Zaika A, Powell SM, Roche J, Crowe S, et al. Expression of tight-junction protein claudin-7 is an early event in gastric tumorigenesis. Am J Pathol. 2005;167:577-84.
12. Resnick MB, Gavilanez M, Newton E, Konkin T, Bhattacharya B, Britt DE, et al. Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation. Hum Pathol. 2005;36:886-92.
13. Oliveira SS, Morgado-Díaz JA. Claudins: multifunctional players in epithelial tight junctions and their role in cancer. Cell Mol Life Sci. 2007;64:17-28.
14. Ohtani S, Terashima M, Satoh J, Soeta N, Saze Z, Kashimura S, et al. Expression of tight-junction-associated proteins in human gastric cancer: downregulation of claudin-4 correlates with tumor aggressiveness and survival. Gastric Cancer. 2009;12:43-51.
15. -ΔΔCT method. Methods. 2001;25:402-8.
16. Farquhar MG, Palade GE. Junctional complexes in various epithelia. J Cell Biol. 1963;17:375-412.
17. Giepmans BN, van Ijzendoorn SC. Epithelial cell-cell junctions and plasma membrane domains. Biochim Biophys Acta. 2009;1788:820-31.
18. Ivanova NB, Dimos JT, Schaniel C, Hackney JA, Moore KA, Lemischka IR. A stem cell molecular signature. SCIENCE. 2002;298:601-4.
19. Fuse C, Ishida Y, Hikita T, Asai T, Oku N. Junctional adhesion molecule-C promotes metastatic potential of HT1080 human fibrosarcoma. J Biol Chem. 2007;282:8276-83.
20. Langer HF, Orlova VV, Xie C, Kaul S, Schneider D, Lonsdorf AS, et al. A novel function of junctional adhesion molecule-C in mediating melanoma cell metastasis. Cancer Res. 2011;71:4096-105.
21. Gatesman A, Walker VG, Baisden JM, Weed SA, Flynn DC. Protein kinase Calpha activates c-Src and induces podosome formation via AFAP-110. Mol Cell Biol. 2004;24:7578-97.
22. Qian Y, Baisden JM, Cherezova L, Summy JM, Guappone-Koay A, Shi X, et al. PC phosphorylation increases the ability of AFAP-110 to cross-link actin filaments. Mol Biol Cell. 2002;13:2311-22.
23. Walker VG, Ammer A, Cao Z, Clump AC, Jiang BH, Kelley LC, et al. PI3 K activation is required for PMA-directed activation of cSrc by AFAP-110. Am J Physiol Cell Physiol. 2007;293:119-32.
24. Dorfleutner A, Stehlik C, Zhang J, Gallick GE. Flynn DC.AFAP-110 is required for actin stress fiber formation and cell adhesion in MDA-MB-231 breast cancer cells. J Cell Physiol. 2007;213(3):740-9.
25. Baisden JM, Gatesman AS, Cherezova L, Jiang BH, Flynn DC. The intrinsic ability of AFAP-110 to alter actin filament integrity is linked with its ability to also activate cellular tyrosine kinases. Oncogene. 2001;20:6607-16.
26. Baisden JM, Qian Y, Zot HM, Flynn DC. The actin filament associated protein AFAP-110 is an adaptor protein that modulates changes in actin filament integrity. Oncogene. 2001;20:6435-47.
27. Zhang J, Park SI, Artime MC, Summy JM, Shah AN, Bomser JA, et al. AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts. J Clin Invest. 2007;117:2962-73.
28. Cunningham SC, Kamangar F, Kim MP, Hammoud S, Haque R, Iacobuzio-Donahue CA, et al. Claudin-4, mitogen-activated protein kinase kinase 4, and stratifin are markers of gastric adenocarcinoma precursor lesions. Cancer Epidemiol Biomarkers Prev. 2006;15:281-7.
29. Satake S, Semba S, Matsuda Y, Usami Y, Chiba H, Sawada N, et al. Cdx2 transcription factor regulates claudin-3 and claudin-4 expression during intestinal differentiation of gastric carcinoma. Pathol Int. 2008;58:156-63.
30. Xin S, Huixin C, Benchang S, Aiping B, Jinhui W, Xiaoyan L, et al. Expression of Cdx2 and claudin-2 in the multistage tissue of gastric carcinogenesis. Oncology. 2007;73:357-65.
31. Song X, Li X, Tang Y, Chen H, Wong B, Wang J, et al. Expression of claudin-2 in the multistage process of gastric carcinogenesis. Histol Histopathol. 2008;23:673-82.
32. Agarwal R, Mori Y, Cheng Y, Jin Z, Olaru AV, Hamilton JP, et al. Silencing of claudin-11 is associated with increased invasiveness of gastric cancer cells. PLoS ONE. 2009;4:e8002.